Lessons learned from a subsidised spectacles scheme aiming to improve eye health in Aboriginal people in Victoria, Australia.


Journal

Australian health review : a publication of the Australian Hospital Association
ISSN: 1449-8944
Titre abrégé: Aust Health Rev
Pays: Australia
ID NLM: 8214381

Informations de publication

Date de publication:
Mar 2021
Historique:
received: 09 02 2020
accepted: 19 06 2020
pubmed: 10 11 2020
medline: 25 6 2021
entrez: 9 11 2020
Statut: ppublish

Résumé

The Victorian Aboriginal Spectacles Subsidy Scheme (VASSS) aimed to improve access to visual aids and eye care for Aboriginal and Torres Strait Islander Victorians. The VASSS started in July 2010 and has operated continually since. In 2016, we explored the collaborations, planning, adaptations and performance of the VASSS over the first 6 years by reviewing and analysing service data, as well as data from semistructured interviews, focus groups and surveys. An estimated 10853 VASSS cofunded visual aids were delivered over 6 years, and the mean annual number of comprehensive eye examinations provided within services using VASSS grew 4.6-fold faster compared with the 4 years preceding the VASSS. We estimate that 16% and 19% of recipients presented with distance and near vision impairments respectively, all of which were corrected with visual aids. VASSS achievements were attained through collaborations, flexibility, trust and communication between organisations, all facilitated by funding resulting from evidence-based advocacy. Access to visual aids and eye examinations by Aboriginal Victorians has improved during the operation of the VASSS, with associated direct and indirect benefits to Aboriginal health, productivity and quality of life. The success of the VASSS may be replicable in other jurisdictions and provides lessons that may be applicable in other fields.

Identifiants

pubmed: 33166246
pii: AH20023
doi: 10.1071/AH20023
doi:

Types de publication

Journal Article

Langues

eng

Pagination

194-198

Auteurs

Timothy R Fricke (TR)

Brien Holden Vision Institute, 2/73 Hartley St, Alice Springs, NT, 0870, Australia. Email: t.fricke@bhvi.org.

Chelsea Brand (C)

Department of Health and Human Services, Victorian Government, 50 Lonsdale St, Melbourne, Vic. 3000, Australia. Email: Chelsea.Brand@dhhs.vic.gov.au.

Levi Lovett (L)

Victorian Aboriginal Community Controlled Health Organisation, 17-23 Sackville St, Collingwood, Vic. 3066, Australia. Email: levi.76@live.com.au.

Neville W Turner (NW)

Australian College of Optometry, National Vision Research Institute, 374 Cardigan St, Carlton, Vic. 3053, Australia. Email: nturner@aco.org.au.

Mitchell D Anjou (MD)

Indigenous Eye Health, Melbourne School of Population and Global Health, The University of Melbourne, Level 5, 207 Bouverie St, Carlton, Vic. 3010, Australia. Email: manjou@unimelb.edu.au.

Sharon A Bentley (SA)

Australian College of Optometry, National Vision Research Institute, 374 Cardigan St, Carlton, Vic. 3053, Australia. Email: nturner@aco.org.au; and School of Optometry and Vision Science, Queensland University of Technology, Victoria Park Rd, Kelvin Grove, Qld 4059, Australia; and Corresponding author. Email: sharon.bentley@qut.edu.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH